Eps8, a therapeutic potential target for cancer
Author:
Publisher
Elsevier BV
Subject
Pathology and Forensic Medicine
Reference5 articles.
1. Eps8 expression is significantly lower in p16+ head and neck squamous cell carcinomas (HNSCC) compared to p16- HNSCC;Nasri;Hum Pathol,2018
2. A dual-function epidermal growth factor receptor pathway substrate 8 (Eps8)–derived peptide exhibits a potent cytotoxic T lymphocyte-activating effect and a specific inhibitory activity;Xie;Cell Death Dis,2018
3. Effect of trichostatin A on Burkitt's lymphoma cells: Inhibition of Eps8 activity through Phospho-Erk1/2 pathway;Sun;Biochem Biophys Res Commun,2018
4. Eps8 regulates proliferation, apoptosis and chemosensitivity in BCR-ABL positive cells via the BCR-ABL/PI3K/AKT/mTOR pathway;Huang;Oncol Rep,2018
5. A synthetic cell-penetrating peptide derived from nuclear localization signal of Eps8 exerts anticancer activity against acute myeloid leukemia;Chen;J Exp Clin Cancer Res,2018
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Loss of EPS8 sensitizes non-small-cell lung carcinoma to chemotherapy-induced DNA damage;Cancer Gene Therapy;2023-03-17
2. MORC4 plays a tumor-promoting role in colorectal cancer via regulating PCGF1/CDKN1A axis in vitro and in vivo;Cancer Gene Therapy;2023-03-17
3. Dexmedetomidine suppresses the progression of esophageal cancer via miR-143-3p/epidermal growth factor receptor pathway substrate 8 axis;Anti-Cancer Drugs;2020-04-16
4. EPS8 is a Potential Oncogene in Glioblastoma;OncoTargets and Therapy;2019-12
EPS8 is a Potential Oncogene in Glioblastoma
5. Upregulation of EPS8L3 is associated with tumorigenesis and poor prognosis in patients with liver cancer;Molecular Medicine Reports;2019-07-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3